A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

Overview of attention for article published in Neurology, July 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 5 news outlets
policy: 2 policy sources
twitter: 14 X users

patent: 3 patents
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 282 Mendeley
connotea: 1 Connotea

So far, Altmetric has seen 3 policy documents that reference this research output.

Causal AI with Real World Data: Do Statins Protect from Alzheimer’s Disease Onset?

Cited by Centers for Disease Control and Prevention (CDC) on 14 Nov 2023

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Dementia: assessment, management and support for people living with dementia and their carers : Appendix I: References

Cited by National Institute for Health and Care Excellence (NICE) on 26 Oct 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Dementia: assessment, management and support for people living with dementia and their carers : Appendix E: Evidence tables

Cited by National Institute for Health and Care Excellence (NICE) on 06 Jun 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.